INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 418m ago
HOUSE PTR17m ago
SEC 13F17m ago
ROBINHOOD CHAIN17m ago
Public company

TVRDTvardi Therapeutics, Inc.

CIK 0001346830

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score9
Connections6with evidence

TVRD · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SD
Shiff Susan Ph.D.Director
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
6,000 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Shiff Susan Ph.D.Director · Jun 11, 2026
  • ← Insider ofevidence
    Conn Avi DanielChief Financial Officer · Dec 18, 2025
  • ← Insider ofevidence
    O'Brien Stephen PaulPrincipal Accounting Officer · Dec 18, 2025
9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A
—
45.0K sh
Jan 29, 2026
Feb 2, 2026
traded Jan 29, 2026
+4d
SEC FORM 4

Evidence

9
OP
O'Brien Stephen PaulPrincipal Accounting Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
15.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

9
AN
Alibhai Imran NizamudinDirector, Chief Executive Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
115.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

9
KD
Kauh John Saewook M.D.Chief Medical Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

9
KD
Kauh John Saewook M.D.Chief Medical Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
17.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

9
AN
Alibhai Imran NizamudinDirector, Chief Executive Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
47.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
17.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

9
OP
O'Brien Stephen PaulPrincipal Accounting Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
4,000 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Alibhai Imran NizamudinDirector, Chief Executive Officer · Dec 18, 2025
  • ← Insider ofevidence
    Kauh John Saewook M.D.Chief Medical Officer · Dec 18, 2025